Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
BOCA RATON, Fla. – Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced that SkinCure Oncology and Sensus Healthcare have amicably resolved their dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence. In March 2026, Sensus […]
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
Dedicated CPT Codes for Superficial Radiotherapy (SRT) Now Effective, Driving Increased Customer Activity, Customer Diversification and Improved Physician Economics Sales Pipeline and Financing Activity Strengthen Following Reimbursement Clarity Expansion of Installed Base and Recurring Revenue Growth Driving Advancement Towards Profitability Exited the Quarter with $18.3 Million in Cash and No Debt BOCA RATON, Fla. – […]
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the first quarter of 2026 on Thursday, May 7, 2026. Management will hold a conference call beginning at 4:30 pm […]
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
Proprietary cloud-based software and add-on solution designed to provide current and future SRT-100 users with enhanced workflow, operating intelligence and clinical utility Creates a scalable, recurring-revenue opportunity for Sensus tied to treatment workflows and necessary oversight services Supports improved unit economics and expands Sensus’ ability to serve Fair Deal Agreement customers and those who purchase […]
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
New financing program provides a “one-stop” pathway for practices to acquire systems through outright purchase or several attractive leasing alternatives Supports improved conversion of late-stage prospects as reimbursement clarity accelerates purchase decisions and lowers breakeven point to only one patient per month BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to delivery code that became effective January 1, 2026 Company enters 2026 with reimbursement certainty and strategic visibility, expects sequential-quarter revenue growth in Q1 and full-year profitability Shipped 14 SRT systems in Q4, most in December and none to its historically largest customer, […]
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. Management will hold a conference call beginning at 4:30 […]
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that management will be meeting with members of the healthcare investment community January 12-14, 2026, in San Francisco during the 44th Annual J.P. Morgan Healthcare […]
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Larry Biscotti to its Board of Directors, effective immediately. With this appointment the Sensus Healthcare Board has six Directors, including four independent […]
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
New responsibilities recognize Mr. Sardano’s significant accomplishments in securing CPT® codes for office-based SRT and the growing commercial opportunity the Company now faces BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced that President […]
